Expertise in
3
conditions

Maria S. Felice

Hospital De Pediatría Prof. Dr. Juan P. Garrahan, 
B, AR 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
3
conditions
Hospital De Pediatría Prof. Dr. Juan P. Garrahan, 
B, AR 

Overview

Maria Felice practices practicing medicine in Argentina.

Ms. Felice is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Leukemia, Acute Megakaryoblastic Leukemia, and L1 Syndrome.

She is actively involved in clinical research, co-authoring 34 peer reviewed articles and participating in 1 clinical trial.

Gender

Female

Locations

Hospital De Pediatría Prof. Dr. Juan P. Garrahan, B, Argentina
Other Locations
Buenos Aires, C, Argentina

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Non Randomized, Multicenter, Prospective Pediatric Hodgkin Lymphoma Treatment Trial Stratified According to Initial Risk Factors and Response to Chemotherapy, Reduced Cumulative Doses of Antineoplastic Agents and Radiotherapy.
Non Randomized, Multicenter, Prospective Pediatric Hodgkin Lymphoma Treatment Trial Stratified According to Initial Risk Factors and Response to Chemotherapy, Reduced Cumulative Doses of Antineoplastic Agents and Radiotherapy.
Enrollment Status: Recruiting
Publish Date: April 16, 2025
Intervention Type: Drug, Radiation
Study Drugs: Doxorubicin, Bleomycin, Vinblastine, Dacarbazine, Etoposide, Prednisolone, Citarabine, Cisplatin
Study Phase: Phase 4

34 Total Publications

Radiotherapy may be omitted in children and adolescents with classical Hodgkin lymphoma in complete remission after frontline risk and response-adapted chemotherapy: a multicenter clinical trial (LH-GALOP 2017).
Radiotherapy may be omitted in children and adolescents with classical Hodgkin lymphoma in complete remission after frontline risk and response-adapted chemotherapy: a multicenter clinical trial (LH-GALOP 2017).
Journal: Leukemia & lymphoma
Published: April 28, 2026

Frequently Asked Questions about Maria S. Felice

Is Maria S. Felice a top-rated expert for Acute Lymphoblastic Leukemia (ALL)?

MediFind is an objective health platform that identifies experts based on real-world data. Maria S. Felice is classified as an Advanced expert for Acute Lymphoblastic Leukemia (ALL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Maria S. Felice participate in research or clinical trials?

Yes. Maria S. Felice has published 34 articles and abstracts on conditions like Acute Lymphoblastic Leukemia (ALL). You can view a list of Maria S. Felice's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Felice's expertise for a condition
ConditionClose
      View All 8 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile